Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2022-2028

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for 23-Valent Pneumococcal Polysaccharide Vaccine by Country/Region, 2017, 2022 & 2028
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2017-2022)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
2.4.1 For Children (2-10)
2.4.2 For Person (10-64)
2.4.3 For The Old (Above or equal to 65)
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2017-2022)
3 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2020-2022)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2020-2022)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region
4.1 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Geographic Region
4.2 World Historic 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue by Country/Region
4.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.4 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.6 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
5 Americas
5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022)
5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022)
6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022)
6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
10.4 Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
11.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer
12 World Forecast Review for 23-Valent Pneumococcal Polysaccharide Vaccine by Geographic Region
12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Region
12.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Region (2023-2028)
12.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type
12.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application
13 Key Players Analysis
13.1 MSD
13.1.1 MSD Company Information
13.1.2 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
13.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 MSD Main Business Overview
13.1.5 MSD Latest Developments
13.2 Sanofipasteur
13.2.1 Sanofipasteur Company Information
13.2.2 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
13.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofipasteur Main Business Overview
13.2.5 Sanofipasteur Latest Developments
13.3 CDIBP
13.3.1 CDIBP Company Information
13.3.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
13.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CDIBP Main Business Overview
13.3.5 CDIBP Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. 23-Valent Pneumococcal Polysaccharide Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Single Dose Vial
Table 4. Major Players of Pre-filled Syringe
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2017-2022) & (US$/Dose)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2017-2022) & (US$/Dose)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2020-2022) & (K Dose)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company (2020-2022) & (US$/Dose)
Table 20. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 21. Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
Table 22. 23-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Geographic Region (2017-2022) & (K Dose)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country/Region (2017-2022) & (K Dose)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 38. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 40. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Dose)
Table 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 46. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 48. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 56. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 58. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 62. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 64. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 66. Key Market Challenges & Risks of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 67. Key Industry Trends of 23-Valent Pneumococcal Polysaccharide Vaccine
Table 68. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 71. 23-Valent Pneumococcal Polysaccharide Vaccine Customer List
Table 72. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Dose)
Table 73. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Forecast by Region
Table 74. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Dose)
Table 77. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Dose)
Table 79. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Dose)
Table 81. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2023-2028) & (K Dose)
Table 83. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2023-2028) & (K Dose)
Table 85. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2023-2028) & (K Dose)
Table 89. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. MSD Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 94. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 95. MSD Main Business
Table 96. MSD Latest Developments
Table 97. Sanofipasteur Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 99. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 100. Sanofipasteur Main Business
Table 101. Sanofipasteur Latest Developments
Table 102. CDIBP Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 104. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 105. CDIBP Main Business
Table 106. CDIBP Latest Developments
List of Figures
Figure 1. Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2017-2028 (K Dose)
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Single Dose Vial
Figure 10. Product Picture of Pre-filled Syringe
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2021
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Children (2-10)
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (2-10) (2017-2022) & (K Dose)
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Person (10-64)
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Person (10-64) (2017-2022) & (K Dose)
Figure 17. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For The Old (Above or equal to 65)
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For The Old (Above or equal to 65) (2017-2022) & (K Dose)
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2021
Figure 21. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2021
Figure 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2022 (K Dose)
Figure 28. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2022 (K Dose)
Figure 30. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2022 (K Dose)
Figure 32. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2022 (K Dose)
Figure 34. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 37. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2021
Figure 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2021
Figure 43. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine in 2021
Figure 64. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 65. Industry Chain Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Influenza Vaccine Market Insights, Forecast to 2029

Published: 25-Sep-2023        Price: US 4900 Onwards        Pages: 107

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them. The global Influenza Vaccine market is project......

2023-2031 Report on Global Avian Influenza Vaccines Market by Player, Region, Type, Application and Sales Channel

Published: 18-Sep-2023        Price: US 2500 Onwards        Pages: 87

This report studies the Avian Influenza Vaccines market, covering market size for segment by type (Type H5, Type H9, etc.), by application (Chicken, Duck & Goose, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merial, CEVA, Zoetis, Elanco (Lohmann), Merck Animal Health, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Avian Influenza ......

2023-2031 Report on Global Avian Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 04-Sep-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Avian Influenza Vaccine market, covering market size for segment by type (H5+H7 Avian Influenza Vaccines, H9 Avian Influenza Vaccines, etc.), by application (Chicken, Duck & Goose, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merial, QYH Biotech, DHN, HVRI, CEVA, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market f......

Global Pneumococcal Polysaccharide Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 22-Aug-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Pneumococcal Polysaccharide Vaccine market: According to our latest research, the global Pneumococcal Polysaccharide Vaccine market looks promising in the next 5 years. As of 2022, the global Pneumococcal Polysaccharide Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and com......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 03-Aug-2023        Price: US 3260 Onwards        Pages: 121

The 23-Valent Pneumococcal Polysaccharide Vaccine market revenue was 2268.96 Million USD in 2022, and will reach 3932.11 Million USD in 2028, with a CAGR of 9.6% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the 23-Valent Pneumococcal Polysaccharide Vaccine industry, and breaks down according to the type, application, and consumption area of 23-Valent Pneumococcal Polysaccharide Vaccine. The report also introduces players in......

Global Seasonal Influenza Vaccine Market (2023 Edition): Analysis By Vaccine Type (Inactivated, Live Attenuated), Valency (Quadrivalent, Trivalent), Age Group, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

Published: 01-Jul-2023        Price: US 2450 Onwards        Pages: 280

Executive Summary Azoth Analytics has released a research report titled "Global Seasonal Influenza Vaccine Market (2023 Edition)" which provides a complete analysis of the Global Seasonal Influenza Vaccine industry in terms of market segmentation By Vaccine Type (Inactivated Influenza Vaccine -IIV, Live Attenuated Influenza Vaccine - LAIV), Valency (Quadrivalent, Trivalent), Age Group (Pediatrics, Adults, Elderly) and By Distribution Channel (Hospitals, Pharmacies, Government Supp......

Global Japanese Encephalitis Vaccine Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 97

The Japanese Encephalitis Vaccine market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Japanese Encephalitis Vaccine industry, and breaks down according to the type, application, and consumption area of Japanese Encephalitis Vaccine. The report also introduces players in the industry from the perspective of the industry chain an......

Global Meningococcal Conjugate Market Insights, Forecast to 2029

Published: 16-Jun-2023        Price: US 4900 Onwards        Pages: 114

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease. Market Analysis and Insights: Global Meningococcal Conjugate Market The global Meningococcal Conjugate market is projected to grow from US$ million in 2023 to ......

Global Encephalitis Vaccination Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 15-Jun-2023        Price: US 3260 Onwards        Pages: 118

The Encephalitis Vaccination market revenue was 52963.61 Million USD in 2022, and will reach 65320.29 Million USD in 2028, with a CAGR of 3.56% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Encephalitis Vaccination industry, and breaks down according to the type, application, and consumption area of Encephalitis Vaccination. The report also introduces players in the industry from the perspective of the industry chain and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs